Y-Intercept (HK)’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Buy
+11,730
New +$267K 0.01% 1457
2022
Q4
– Sell
-13,273
Closed -$452K – 1278
2022
Q3
$452K Buy
+13,273
New +$491K 0.05% 571
2021
Q4
– Sell
-9,388
Closed -$221K – 821
2021
Q3
$221K Buy
+9,388
New +$328K 0.04% 552

Other funds holding PRVA

Y-Intercept (HK)'s PRVA Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Privia Health (PRVA) in Q3 2026: 11,730 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #1457 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PRVA as recently as Q3 2022.

Y-Intercept (HK) first reported a position in PRVA in Q3 2021 and has held it in 3 quarters since. The position peaked at $452K in Q3 2022. 91 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Y-Intercept (HK) held 11,730 shares of Privia Health worth $231K as of Q3 2026.
  • Privia Health was a new Y-Intercept (HK) position in Q3 2026.
  • Privia Health made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1457 holding.
  • Y-Intercept (HK) first reported a position in Privia Health in Q3 2021 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Privia Health position peaked at $452K in Q3 2022.
  • 91 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.